Technavio analysts forecast the global human vaccine market to grow at a CAGR of close to 8% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181026005423/en/
Technavio has published a new market research report on the global human vaccine market for the period 2018-2022. (Graphic: Business Wire)
The varied demand for vaccines in high income and developing regions is one of the major trends being witnessed in the global human vaccine market 2018-2022. The demand for novel vaccines is high in developing countries, which receive financial support. Multiple large and small players from developing countries have emerged in the vaccine segment, including Biocon, Bharat Biotech, and Serum Institute of India. There have been some of the major investments by few leading players in the vaccine segment. For instance, on March 6, 2018, Thermis Bioscience and CEPI announced a partnership under which Thermis Bioscience will provide manufacturing and advanced vaccine development for Lassa fever and MERS, and funding will be enabled for five years.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
According to Technavio analysts, one of the key factors contributing to the growth of the global human vaccine market is the increase in investments in the vaccines segment:
Global human vaccine market: Increase in investments in the vaccines segment
High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product, and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.
According to a senior analyst at Technavio for research on vaccines, "It is essential for manufacturers, regulators, and suppliers to work together to understand the challenges and opportunities in this segment. Companies across the world are increasingly investing in the new vaccine development."
Global human vaccine market: Segmentation analysis
The global human vaccine market research report provides market segmentation by route of administration (oral, intramuscular, intradermal, subcutaneous, and intranasal) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The Americas held the largest share of the market in 2017, accounting for more than 48% share, followed by EMEA and APAC respectively. The dominance of the region can be due to the increasing prevalence of infectious diseases and significant rise in the number of government initiatives.
Looking for more information on this market? Request a free sample report
Technavio's sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181026005423/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com